Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

FDAnews Announces -- Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management Webinar July 29, 2020


FALLS CHURCH, Va., July 15, 2020 /PRNewswire-PRWeb/ -- Pharmaceutical Quality Risk Management
Navigating the Intersection Between Regulatory Requirements & Risk Management
An FDAnews Webinar
Wednesday, July 29, 2020, 11:00 a.m.-12:30 p.m. EDT
https://www.fdanews.com/pharmaqrk

Risk is everywhere. And growing. Struggling to manage the types ? and severity ? of risk with Quality Risk Management (QRM) techniques?

QRM must be applied consistently to an ever-increasing roster of drug development, manufacturing, distribution, and inspection and submissions review processes. If one is exerting a huge effort but still feels adrift, this webinar is the answer.

Amanda McFarland, a QRM and microbiology senior consultant with ValSource, Inc., will explain the regulations relative to risk management and explain how to apply QRM's principles to achieve compliance and maintain a competitive advantage. She will:

Given that organizations have made or are currently making decisions about how to maintain production levels in light of the novel coronavirus, this is an incredible opportunity: Ms. McFarland will assist one in exploring the risks and applying risk-based decisionmaking to ensure the long-term impacts of a company's current decisions are fully understood.

Come away with the tools needed to ensure the QRM works to keep one compliant and moving forward.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:
Pharmaceutical Quality Risk Management
Navigating the Intersection Between Regulatory Requirements & Risk Management
An FDAnews Webinar
Wednesday, July 29, 2020, 11:00 a.m.-12:30 p.m. EDT
https://www.fdanews.com/pharmaqrk

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/pharmaqrk
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDAnews


These press releases may also interest you

at 11:25
Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that it has rescheduled its Fiscal First Quarter 2021 financial results conference call,...

at 11:25
The CarolinaEast Health System (CarolinaEast) Board of Directors and the UNC Health Board of Directors announced approval today of an agreement for CarolinaEast to become part of the UNC Health family through a comprehensive affiliation. Together,...

at 11:23
The American Pharmacists Association (APhA) today announced the formation of a fund that will support legal, legislative, and regulatory actions on behalf of pharmacy and the patients who rely on pharmacists' care. The fund will accept donations from...

at 11:20
Theratechnologies Inc. (Theratechnologies, or Company) , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today held its annual meeting of shareholders. As part of the meeting, shareholders...

at 11:15
The "Investigation Report on China's Lenalidomide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Lenalidomide is an oral immunomodulatory drug that is mainly used to treat blood cancers such as multiple myeloma,...

at 11:14
Insmed Incorporated announced today the closing of the previously announced registered underwritten public offering (the "Equity Offering") of 11,500,000 shares of its common stock (the "Shares"), including 1,500,000 Shares issued pursuant to the...



News published on 15 july 2020 at 00:00 and distributed by: